STEMPOINT CAPITAL LP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1952142 NEW YORK, NY

Position in AMLX

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$9,308,621

+$2,481,730 QoQ

Shares Held

669,685

+18.5% QoQ

Ownership

0.602%

of shares outstanding

% of Portfolio

1.78%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

4 quarters on record

Voting authority Sole 87.6071585894861.ToString("F0")% Shared 0.ToString("F0")% None 12.392841410513897.ToString("F0")%

Healthcare · as of Mar 31, 2026

STEMPOINT CAPITAL LP holds $18,077,876 across 3 Drug Manufacturers - Specialty & Generic names. AMLX ranks #1 (51.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMLX	Amylyx Pharmaceuticals, Inc. This page	669,685	$9,308,621
2	BIOA	BioAge Labs, Inc.	338,654	$5,923,058
3	ALKS	Alkermes plc.	80,492	$2,846,197

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,308,621	669,685	+18.5%	Shares	Sole	2026-05-18
2025-12-31	$6,826,891	565,140	+104.1%	Shares	Sole	2026-02-17
2025-09-30	$3,762,853	276,884	+232.1%	Shares	Sole	2025-11-14
2023-12-31	$1,227,368	83,381	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.